<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02988804</url>
  </required_header>
  <id_info>
    <org_study_id>HCB.2016.0781</org_study_id>
    <nct_id>NCT02988804</nct_id>
  </id_info>
  <brief_title>Effects on the Awakening With Laryngeal Mask vs Endotracheal Tube in Endoscopic Endonasal Transsphenoidal Base Surgery</brief_title>
  <official_title>Effects on the Awakening With Laryngeal Mask vs Endotracheal Tube in Endoscopic Endonasal Transsphenoidal Base Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion Clinic per a la Recerca Biomédica</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion Clinic per a la Recerca Biomédica</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The endoscopic endonasal transsphenoidal surgery (EETS) is widely used. Although the&#xD;
      incidence of complications is low, hypertensive episodes during surgery and awakening and&#xD;
      cerebro spinal fluid (CSF) leakage have been described. The occurrence of coughing or&#xD;
      vomiting during the early postoperative period must be avoid to protect the patient from CSF&#xD;
      leakage and arterial hypertension. The emergency of anesthesia with laryngeal mask has a&#xD;
      better haemodynamic profile and less incidence of cough in some surgical procedures and it&#xD;
      could help minimizing the risks after EETS&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomization&#xD;
&#xD;
      At the end of surgery, the anesthesiologist will open a sealed envelope labeled with&#xD;
      software-generated randomized numbers to assign the patients, who will be allocated in a 1:1&#xD;
      ratio from nonstratified blocks of four patients, to one of two groups to emerge from&#xD;
      anesthesia with the ETT still in place (ETT group) or after it has been replaced by a LMA&#xD;
      (LMA group).&#xD;
&#xD;
      Study procedure&#xD;
&#xD;
      In the LMA group, after aspirating pharyngeal secretions and with the patient still under&#xD;
      general anesthesia, the investigators will insert a Proseal LMA (Laryngeal Mask Co. Ltd., Le&#xD;
      Rocher, Victoria, Mahe Seychelles) and extubate the trachea using a guided Bailey technique.&#xD;
      Specifically, the LMA will be inserted after first advancing a suction catheter along the&#xD;
      drain tube 8-10 cm beyond the distal end; the mask will be then inserted using a digital&#xD;
      technique behind the orotracheal tube, allowing the suction catheter to enter the esophagus&#xD;
      first and guiding the tip of the cuff. A number 4 or 5 mask will be chosen for patients&#xD;
      weighing 50-70 kg or 70-100 kg, respectively. The cuff will be inflated to a pressure of 60&#xD;
      cmH2O measured with a manometer. Then the orotracheal tube balloon will be deflated and the&#xD;
      tube removed. Ventilation then will be continued with the same parameters as had been used&#xD;
      earlier.&#xD;
&#xD;
      Administration of neuromuscular relaxants will be then stopped so the patient could emerge&#xD;
      from anesthesia. Once the patient recover 2/4 responses of the TOF, neostigmine (0.03 mg/Kg)&#xD;
      and atropine (0.01mg/kg) will be given to reverse the neuromuscular blockade and&#xD;
      Target-controlled infusion of anesthetics will be stopped. Lidocaine will not be&#xD;
      administrated.&#xD;
&#xD;
      Gentle manual ventilator assistance will be then provided until the patient resume&#xD;
      spontaneous breathing and respond to simple commands; the LMA or the ETT, depending on the&#xD;
      group, will be then removed.&#xD;
&#xD;
      The investigators will administer prophylaxis of nausea in the postoperative period with&#xD;
      ondansetron 4 mg/8h/iv.&#xD;
&#xD;
      In the ETT group, the procedure will be exactly the same except that the ETT will not be&#xD;
      exchanged and the patient will be directly extubated when the patient will fulfill the same&#xD;
      criteria.&#xD;
&#xD;
      Parameters&#xD;
&#xD;
      Patient variables (age, weight, height, sex) and relevant aspects of past medical history,&#xD;
      such as:&#xD;
&#xD;
        -  controlled hypertension&#xD;
&#xD;
        -  tobacco addiction&#xD;
&#xD;
        -  respiratory disease will be also registered, including sleep apnea and any chronic&#xD;
           respiratory disease (chronic bronquitis, emphysema, chronic pulmonary obstructive&#xD;
           disease).&#xD;
&#xD;
        -  cough test&#xD;
&#xD;
      Diagnosis, type of surgery, the placement of lumbar drainage.&#xD;
&#xD;
      Hemodynamic variables (blood pressure, HR, CO, rSO2, TCD) will be recorded at 8 moments:&#xD;
&#xD;
        -  baseline, in the operating room before anesthetic induction (non invasive arterial&#xD;
           pressure)&#xD;
&#xD;
        -  end of surgery, before awakening (ETT group) or before ETT replacement (LMA group)&#xD;
&#xD;
        -  at 1, 5, 10, 15, 30 and 60 min after extubation or LMA removal (according to group&#xD;
           assignment).&#xD;
&#xD;
      The last blood pressure and HR measurements will be taken in the postoperative recovery room.&#xD;
      Respiratory variables (including end-tidal carbon dioxide concentration) will be controlled&#xD;
      during MV.&#xD;
&#xD;
        -  Neurosurgeon will rate the amount of blood in the surgical field (1: no blood; 2: small&#xD;
           bleeding that does not interfere with surgery; 3: bleeding that interferes with surgery&#xD;
           but surgery is possible; 4: bleeding that impedes normal development of surgery).&#xD;
&#xD;
        -  Any coughing episode during the first 5 minutes of awakening. Considering light coughing&#xD;
           (1 cough) and strong coughing (access of cough).&#xD;
&#xD;
        -  Preoperative xylometazoline administration.&#xD;
&#xD;
        -  Intraoperative hypertension and antihypertensive agent administered.&#xD;
&#xD;
        -  Endotracheal tube size and laryngeal mask size.&#xD;
&#xD;
        -  Difficulties in LMA ventilation.&#xD;
&#xD;
        -  Postoperative nausea or vomiting&#xD;
&#xD;
        -  CSF leakage during the admission and in the first month.&#xD;
&#xD;
        -  Postoperative bleeding.&#xD;
&#xD;
      The objective of the investigators study is evaluate the incidence of coughing and&#xD;
      hypertension during awakening in patients after EETS comparing the effect of laryngeal mask&#xD;
      vs orotracheal tube.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 20, 2017</start_date>
  <completion_date type="Actual">December 5, 2019</completion_date>
  <primary_completion_date type="Actual">November 5, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>systolic blood pressure</measure>
    <time_frame>changes from baseline systolic blood pressure in the first 60 minutes after extubation</time_frame>
    <description>Changes in systolic blood pressure comparing two methods lma vs ett</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>noradrenaline levels</measure>
    <time_frame>changes from baseline noradrenaline level at 30 minutes after awakening</time_frame>
    <description>Compare noradrenaline levels in both groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Skull Base Neoplasms</condition>
  <arm_group>
    <arm_group_label>endotracheal tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procedure: Endotracheal tube&#xD;
Hemodynamic variables (blood pressure, HR, CO, rSO2, TCD) will be recorded at 8 moments:&#xD;
baseline, in the operating room before anesthetic induction (non invasive arterial pressure)&#xD;
end of surgery, before awakening (ETT group) or before ETT replacement (LMA group)&#xD;
at 1, 5, 10, 15, 30 and 60 min after extubation or LMA removal (according to group assignment).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laryngeal mask</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Procedure: Laryngeal mask&#xD;
Hemodynamic variables (blood pressure, HR, CO, rSO2, TCD) will be recorded at 8 moments:&#xD;
baseline, in the operating room before anesthetic induction (non invasive arterial pressure)&#xD;
end of surgery, before awakening (ETT group) or before ETT replacement (LMA group)&#xD;
at 1, 5, 10, 15, 30 and 60 min after extubation or LMA removal (according to group assignment).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>endotracheal tube</intervention_name>
    <description>In the Endotracheal group In the ETT group, the procedure will be exactly the same except that the ETT will not be exchanged and the patient will be directly extubated&#xD;
Hemodynamic variables (blood pressure, HR, CO, rSO2, TCD) will be recorded at 8 moments:&#xD;
baseline, in the operating room before anesthetic induction (non invasive arterial pressure)&#xD;
end of surgery, before awakening (ETT group) or before ETT replacement (LMA group)&#xD;
at 1, 5, 10, 15, 30 and 60 min after extubation or LMA removal (according to group assignment).</description>
    <arm_group_label>endotracheal tube</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laryngeal mask</intervention_name>
    <description>In the LMA group, after aspirating pharyngeal secretions and with the patient still under general anesthesia, we will insert a Proseal LMA (Laryngeal Mask Co. Ltd., Le Rocher, Victoria, Mahe Seychelles) and extubate the trachea using a guided Bailey technique&#xD;
Hemodynamic variables (blood pressure, HR, CO, rSO2, TCD) will be recorded at 8 moments:&#xD;
baseline, in the operating room before anesthetic induction (non invasive arterial pressure)&#xD;
end of surgery, before awakening (ETT group) or before ETT replacement (LMA group)&#xD;
at 1, 5, 10, 15, 30 and 60 min after extubation or LMA removal (according to group assignment).</description>
    <arm_group_label>Laryngeal mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who undergo EETS in Hospital Clínic de Barcelona&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Re-interventions&#xD;
&#xD;
          -  Predicted difficult airway (severe acromegalia, mouth opening reduction) or&#xD;
             Cormack-Lehane grade IV detected during laryngoscopy&#xD;
&#xD;
          -  Risk of bronchial aspiration (e.g., gastroesophageal reflux disease or lower cranial&#xD;
             nerve palsy)&#xD;
&#xD;
          -  Uncontrolled arterial hypertension detected during preoperative assessment&#xD;
&#xD;
          -  Contraindication for early emergence based on anaesthetic or surgical criteria or as a&#xD;
             result of complications developing during surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paola Hurtado, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Senior Especialist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Anesthesia department, Hospital Clínic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08019</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>December 1, 2016</study_first_submitted>
  <study_first_submitted_qc>December 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2016</study_first_posted>
  <last_update_submitted>May 27, 2020</last_update_submitted>
  <last_update_submitted_qc>May 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundacion Clinic per a la Recerca Biomédica</investigator_affiliation>
    <investigator_full_name>Ricard Valero</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>endoscopic endonasal transsphenoidal surgery</keyword>
  <keyword>laryngeal mask</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skull Base Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

